Advertisement

Topics

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

15:39 EDT 3 Aug 2017 | CentreWatch

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases. Cardurion is led by two physician scientists with extensive experience in cardiovascular science, medicine […]

The post Takeda, Cardurion Pharmaceuticals partner on cardiovascular development appeared first on CenterWatch News Online.

Original Article: Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

NEXT ARTICLE

More From BioPortfolio on "Takeda, Cardurion Pharmaceuticals partner on cardiovascular development"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...